{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:51:35Z","timestamp":1767340295733},"reference-count":12,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Somatic mosaicism because of in vivo reversion has been recently reported in a small number of patients affected with Wiskott-Aldrich syndrome (WAS). Flow cytometry analysis of WAS protein (WASP) expression has shown that these patients carried revertant cells only among T lymphocytes. Here, we have used high-resolution capillary electrophoresis to analyze genomic DNA from highly purified cells of one of these patients and detected revertant sequences also within the B-cell fraction. The demonstration of revertant cells among both T and B lymphocytes in this patient is consistent with the reversion event having occurred in a common lymphoid progenitor. However, although WASP-expressing T cells showed selective advantage and were readily detectable in the periphery of the mosaic patient, revertant B lymphocytes remained below the detection threshold of flow cytometry. These findings suggest that, contrary to T cells, differentiation and survival of B lymphocytes is minimally dependent on WASP.<\/jats:p>","DOI":"10.1182\/blood-2003-05-1739","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T01:36:27Z","timestamp":1064280987000},"page":"676-678","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages"],"prefix":"10.1182","volume":"103","author":[{"given":"Akihiro","family":"Konno","sequence":"first","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Wada","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shepherd H.","family":"Schurman","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Garabedian","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Kirby","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacie M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Candotti","sequence":"additional","affiliation":[{"name":"From the Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health (NIH); and the Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021217333004700_REF1","doi-asserted-by":"crossref","unstructured":"Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001; 166: 5245-5249.","DOI":"10.4049\/jimmunol.166.8.5245"},{"key":"2020021217333004700_REF2","doi-asserted-by":"crossref","unstructured":"Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A. 2001;98: 8697-8702.","DOI":"10.1073\/pnas.151260498"},{"key":"2020021217333004700_REF3","doi-asserted-by":"crossref","unstructured":"Wada T, Konno A, Schurman SH, et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest. 2003;111: 1389-1397.","DOI":"10.1172\/JCI15485"},{"key":"2020021217333004700_REF4","doi-asserted-by":"crossref","unstructured":"Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet. 1996;13: 290-295.","DOI":"10.1038\/ng0796-290"},{"key":"2020021217333004700_REF5","doi-asserted-by":"crossref","unstructured":"Arredondo-Vega FX, Santisteban I, Richard E, et al. Adenosine deaminase deficiency with mosaicism for a \u201csecond-site suppressor\u201d of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood. 2002;99: 1005-1013.","DOI":"10.1182\/blood.V99.3.1005"},{"key":"2020021217333004700_REF6","doi-asserted-by":"crossref","unstructured":"Gregory JJ Jr, Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci U S A. 2001;98: 2532-2537.","DOI":"10.1073\/pnas.051609898"},{"key":"2020021217333004700_REF7","doi-asserted-by":"crossref","unstructured":"Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O'Donnell E. Wiskott-Aldrich syndrome in a female. Blood. 2002;100: 2763-2768.","DOI":"10.1182\/blood-2002-02-0388"},{"key":"2020021217333004700_REF8","doi-asserted-by":"crossref","unstructured":"Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9: 81-91.","DOI":"10.1016\/S1074-7613(00)80590-7"},{"key":"2020021217333004700_REF9","doi-asserted-by":"crossref","unstructured":"Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med. 1999;190: 1329-1342.","DOI":"10.1084\/jem.190.9.1329"},{"key":"2020021217333004700_REF10","doi-asserted-by":"crossref","unstructured":"Meuwissen HJ, Bortin MM, Bach FH, et al. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome. J Pediatr. 1984;105: 365-369.","DOI":"10.1016\/S0022-3476(84)80006-2"},{"key":"2020021217333004700_REF11","doi-asserted-by":"crossref","unstructured":"Brunel V, Mozziconacci MJ, Sainty D, et al. Direct evidence for dissociated megakaryocytic chimaerism in a Wiskott-Aldrich patient successfully allografted. Br J Haematol. 1995;90: 336-340.","DOI":"10.1111\/j.1365-2141.1995.tb05155.x"},{"key":"2020021217333004700_REF12","doi-asserted-by":"crossref","unstructured":"Yamaguchi K, Ariga T, Yamada M, et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood. 2002;100: 1208-1214.","DOI":"10.1182\/blood-2002-01-0211"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/676\/1694867\/zh800204000676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/676\/1694867\/zh800204000676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T23:27:58Z","timestamp":1581550078000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/2\/676\/17868\/Differential-contribution-of-WiskottAldrich"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,15]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-05-1739","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,15]]}}}